dr. zhang on the imvigor130 trial in metastatic urothelial cancer
Published 4 years ago • 199 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
0:52
dr. davis on imvigor130 trial in metastatic urothelial cancer
-
2:18
final os results of imvigor130: 1l atezolizumab /- chemotherapy in metastatic urothelial carcinoma
-
0:54
dr. singh on potential implications of the imvigor130 trial in bladder cancer
-
5:27
imvigor130: atezolizumab with or without chemotherapy in metastatic urothelial cancer
-
2:04
dr. grivas on the imvigor211 trial in metastatic urothelial carcinoma
-
2:57
phase 3 imvigor130 results: atezolizumab in untreated metastatic urothelial carcinoma
-
0:48
imvigor130: 1l atezolizumab /- chemotherapy in metastatic urothelial carcinoma
-
1:27
dr. zhang discusses the impact of the stampede trial in prostate cancer
-
3:03
imvigor130: immunotherapy added to chemotherapy in metastatic urothelial cancer
-
1:32
dr. zhang on the impact of the latitude study in prostate cancer
-
1:55
imvigor130: a post-hoc analysis of atezolizumab monotherapy in urothelial carcinoma
-
1:47
dr. zhang discusses neoadjuvant therapy in kidney cancer
-
2:19
dr. galsky discusses the rationale for the imvigor130 study in bladder cancer
-
2:25
characterization of circulating immune cells in metastatic urothelial cancer following treatment
-
4:20
imvigor130 data: atezolizumab alone or with chemo upfront for bladder cancer
-
1:25
dr. balar on imvigor 210 results for metastatic urothelial carcinoma
-
7:21
imvigor130: atezolizumab /- platinum-based chemo upfront for advanced urothelial carcinoma
-
3:32
value of pd-l1 testing in metastatic urothelial cancer
-
6:49
fda approval of atezolizumab for advanced bladder cancer